According to multiple reports, a 51-year-old man with limb-girdle muscular dystrophy died from acute liver failure after ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Overall venture funding, as well as “first financing” rounds, fell significantly in the second quarter, erasing what had been ...

The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Quarterly pharmaceutical sales surpassed $15 billion for the first time as strong performance from J&J's cancer medicines ...

On a conference call, CEO Doug Ingram said the decision to cut 36% of the company's staff and halt several drug programs was ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

The results position Hengrui to seek approval of the Zepbound-like drug in China, and Kailera, a well-funded startup, to ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

Some two dozen biotech developers of PROTACs, molecular glues and other types of protein-degrading drugs have sprung up over ...